Phase I/II dose-escalation and expansion study of afuresertib plus carboplatin and paclitaxel in recurrent ovarian cancer.

Sarah Patricia Blagden, Hani Gabra, Anne L. Hamilton, Shirley S. Wong, Agnieszka Michael, Linda R. Mileshkin, Marcia Hall, Jeffrey Goh, Alla Sergeevua Lisyanskaya, Michelle DeSilvio, Dany Habr, Shelby Gainer, Prashanth Gopalakrishna, Tarek Meniawy

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

2 Citations (Web of Science)
Original languageEnglish
Number of pages2
JournalJournal of Clinical Oncology
Issue number15
Publication statusPublished - 20 May 2016
EventAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, United States
Duration: 3 Jun 20167 Jun 2016

Cite this